TrialFuture oncology (London, England)2025

RELAY: safety and efficacy of ramucirumab plus erlotinib in elderly Japanese patients with metastatic

Kazumi Nishino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.